In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Maria Generosa Crespo-Leiro
Speaker
Maria Generosa Crespo-Leiro
Maria Generosa Crespo-Leiro Maria Generosa Crespo-Leiro

University Hospital A Coruna, A Coruna (Spain)

Specialities : Chronic Heart Failure , Chronic Heart Failure

Head, Heart Failure Section, Cardiology Service at the Complexo Hospitalario Universitario A Coruña (CHUAC), Spain. Professor of Medicine, University of A Coruña (UDC) She obtained MD at the University of Santiago de Compostela, Specialization in Cardiology at Clinica Puerta de Hierro (Madrid) and PhD from Universidad Autónoma (Madrid). She served in several scientific societies: President of the Spanish Working Group on HF and HT (2003-2006); Board of Directors, International Society for Heart and Lung Transplantation (ISHLT) (2010-1013). Board member of the Heart Failure Association (HFA) of the ESC (2012-2018). Secretary of the HFA Executive Committee (2016-2018). Chair of the HFA Advanced HF Committee (2017-2018). She is currently a member of the ESC Education Committee. Her main fields of research interest are HF and HT. She chaired the ESC HF Long-term Registry (2013-2016), the HFA scientific statement on advanced HF (2018) and the Spanish post-HT Tumor Registry.

30 presentations from this speaker

Current management of advanced heart failure.

Event : ESC Congress 2020

  • Session : Chronic Heart Failure - Essential Update
  • Speaker : M Crespo-Leiro (La Coruna,ES)

Treating hyperkalaemia: A step towards achieving optimal RAASi therapy?

Event : HFA Discoveries 2020

  • Session : Treating hyperkalaemia: A step towards achieving optimal RAASi therapy?
  • Speaker : P Ponikowski (Wroclaw,PL), A Coats (Warwickshire,GB), I Pina (Detroit,US), M Kosiborod (Kansas,US), M Crespo-Leiro (La Coruna,ES)
  • Organised by CHANGE IME in partnership with Leicester Diabetes Centre Sponsored by an unrestricted educational grant from AstraZeneca

Do we equally treat women and men with heart failure?

Event : Heart Failure 2019

  • Session : Female heart failure: what is different?
  • Speaker : M Crespo-Leiro (La Coruna,ES)

Mechanical circulatory support in heart failure: what’s new

Event : ESC Congress 2019

  • Session : Interventional therapy for heart failure
  • Speaker : M Crespo-Leiro (La Coruna,ES)

mHealth-related improvement in heart failure outcomes: facts or fiction?

Event : ESC Congress 2019

  • Session : Digital cardiovascular health solutions
  • Speaker : M Crespo-Leiro (La Coruna,ES)

Recent epidemiologic data: HFA advanced centers map.

Event : Heart Failure 2019

  • Session : Advanced heart failure: Update 2019
  • Speaker : M Crespo-Leiro (La Coruna,ES)

Serum microRNA-181a-5p expression pattern correlates with acute cellular rejection in heart transplantation

Event : ESC Congress 2019

  • Session : Biomarkers in heart failure
  • Speaker : M Crespo-Leiro (La Coruna,ES)

Idarucizumab for urgent dabigatran reversal at the heart transplantation surgery. Multicenter experience from Spain

Event : Heart Failure 2018

  • Session : Cardiovascular Surgery - Other
  • Speaker : M Crespo-Leiro (La Coruna,ES)

Polymorphisms in Fc receptor genes are related to antibody-mediated rejection after heart transplantation.

Event : ESC Congress 2018

  • Session : Advanced heart failure: new aspects
  • Speaker : M Crespo-Leiro (La Coruna,ES)

Advancing standard of care in patients with HFrEF – what does it take?

Event : ESC Congress 2017

  • Session : Evolving clinical practice for optimized treatment of patients with heart failure with reduced ejection fraction (HFrEF)
  • Speaker : A Pathak (Toulouse,FR), R Wachter (Leipzig,DE), M Crespo-Leiro (La Coruna,ES), AP Maggioni (Milano,IT), RS Gardner (Linithgow,GB)
  • Sponsored by Novartis Pharma AG

Case presentation: a patient with advanced heart failure

Event : Heart Failure 2017

  • Session : Guidelines in Daily Practice V: arrhythmias and devices
  • Speaker : M Crespo-Leiro (La Coruna,ES)

Could my patient with advanced HF benefit from an MCS?

Event : Heart Failure 2017

  • Session : Ventricular assist systems: success and challenges
  • Speaker : M Crespo-Leiro (La Coruna,ES)

From cardiac rejection monitoring to immunologic follow-up after heart transplantation

Event : ESC Congress 2017

  • Session : 50 years of heart transplantation: current challenges and considerations
  • Speaker : M Crespo-Leiro (La Coruna,ES)

Introduction - Evolving clinical practice for optimized treatment of patients with HFrEF.

Event : ESC Congress 2017

  • Session : Evolving clinical practice for optimized treatment of patients with heart failure with reduced ejection fraction (HFrEF)
  • Speaker : AP Maggioni (Milano,IT), M Crespo-Leiro (La Coruna,ES)
  • Sponsored by Novartis Pharma AG

Registry and survey information from Spain: problems and opportunities in improving care for chronic heart failure

Event : ESC Congress 2017

  • Session : Chronic heart failure - The "Big Picture"
  • Speaker : M Crespo-Leiro (La Coruna,ES)

Summary and closure - Evolving clinical practice for optimized treatment of patients with HFrEF.

Event : ESC Congress 2017

  • Session : Evolving clinical practice for optimized treatment of patients with heart failure with reduced ejection fraction (HFrEF)
  • Speaker : M Crespo-Leiro (La Coruna,ES)
  • Sponsored by Novartis Pharma AG

Women's heart in my daily practice.

Event : Heart Failure 2017

  • Session : Off the record with M. Crespo-Leiro
  • Speaker : M Crespo-Leiro (La Coruna,ES)

Heart failure registries in Europe

Event : ESC Congress 2016

  • Session : From Guidelines implementation to new therapies in heart failure
  • Speaker : M Crespo-Leiro (La Coruna,ES)
  • Joint with the Argentine Society of Cardiology

Awards and question and answer.

Event : Heart Failure 2015

  • Session : The RAASi debate: should RAAS blockade continue with a declining eGFR?
  • Speaker : M Crespo-Leiro (La Coruna,ES)
  • Sponsored by ZS Pharma, Inc.

How we did it.

Event : Heart Failure 2015

  • Session : How to set up an heart failure service ?
  • Speaker : M Crespo-Leiro (La Coruna,ES)

Insuficiencia cardiaca avanzada: asistencia mecanica circulatoria y trasplante cardiaco.

Event : Heart Failure 2015

  • Session : Organización de la atención a la insuficiencia cardiaca en España. Estrategia sistema nacional de salud (SNS)
  • Speaker : M Crespo-Leiro (La Coruna,ES)

New therapies in hyperkalemia.

Event : Heart Failure 2015

  • Session : The RAASi debate: should RAAS blockade continue with a declining eGFR?
  • Speaker : M Crespo-Leiro (La Coruna,ES)
  • Sponsored by ZS Pharma, Inc.

Presentation of the Registry results.

Event : Heart Failure 2015

  • Session : EORP heart failure registry: 1 year follow up results
  • Speaker : M Crespo-Leiro (La Coruna,ES)

Welcome and introductions.

Event : Heart Failure 2015

  • Session : The RAASi debate: should RAAS blockade continue with a declining eGFR?
  • Speaker : M Crespo-Leiro (La Coruna,ES)
  • Sponsored by ZS Pharma, Inc.

Welcome from the scientific chairpersons.

Event : Heart Failure 2015

  • Session : Inaugural Session
  • Speaker : F Ruschitzka (Zurich,CH), M Crespo-Leiro (La Coruna,ES)

Heart failure units: cardiologist, internist, geriatrician? The Spanish experience.

Event : ESC Congress 2014

  • Session : Optimising the clinical management of a complex clinical syndrome: the heart failure paradigm
  • Speaker : M Crespo-Leiro (La Coruna,ES)

Pharmacological therapy: update 2014.

Event : ESC Congress 2014

  • Session : Challenges in the management of advanced heart failure
  • Speaker : M Crespo-Leiro (La Coruna,ES)

What is an ideal heart failure service?

Event : ESC Congress 2014

  • Session : How to set up a heart failure service?
  • Speaker : M Crespo-Leiro (La Coruna,ES)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are